safeti efficaci oral flecainid therapi patient atrioventricular re-entr tachycardia object short- long-term safeti efficaci oral flecainid therapi patient symptomat tachycardia extranod accessori pathway design open-label uncontrol trial mean follow-up month set referral-bas medic center patient sixty-thre patient symptomat tachycardia extranod accessori pathway intervent patient electrophysiolog test initi oral flecainid therapi long-term presenc symptom new physic limit advers effect therapi measur main result flecainid therapi ms ms induc atrioventricular tachycardia patient patient hospit flecainid therapi advers effect mean follow-up month advers cardiac reaction proarrhythmia sinu node suppress attribut patient patient event in-hospit monitor electrophysiolog studi discharg structur heart diseas two-dimension echocardiographi patient advers cardiac event patient event isoproterenol effect flecainid therapi patient patient spontan clinic recurr tachycardia palpit follow-up period symptom patient isoproterenol-induc revers conclus oral flecainid therapi effect patient tachycardia extranod accessori connect hospit monitor initi therapi flecainid caution patient structur heart diseas isoproterenol challeng help late recurr tachycardia 